The Cost of Patients With Relapsing-Remitting Multiple Sclerosis Who Develop Neutralizing Antibodies While Treated With Interferon Beta
Nov 1, 2015, 00:00
10.1016/j.jval.2015.09.2925
https://www.valueinhealthjournal.com/article/S1098-3015(15)05006-8/fulltext
Title :
The Cost of Patients With Relapsing-Remitting Multiple Sclerosis Who Develop Neutralizing Antibodies While Treated With Interferon Beta
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)05006-8&doi=10.1016/j.jval.2015.09.2925
First page :
A754
Section Title :
Research Podium Presentations - Session 1 and Session 2
Open access? :
No
Section Order :
2325